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Abstract:
Echinacea purpurea is an herbal supplement used to reduce symptoms of
common colds and flu-like illnesses. As of right now, it is not well understood what
chemical components in the plant are immunologically active. The four main potentially
immunologically active chemical components in E. purpurea are caffeic acid derivatives,
alkamides, polyacetylenes, and polysaccharides. In this investigation, a protocol was
developed in an attempt to identify polysaccharides present in Puritan’s Pride E.
purpurea (aerial) “non-irradiated” herbal supplement First, an estimate of the crude total
polysaccharide content in Puritan’s Pride and in a ChromaDex certified botanical
standard (E. purpurea -powdered root) was performed and yielded 7.1% of the aerial
plant material and 0.12% of the root material; respectively. To identify the individual
polysaccharides present in E. purpurea, conversion into a form amenable for analysis by
GC/MS (gas chromatography/mass spectrometry) required a sequential process of
methylation, hydrolysis, reduction and acetylation to produce partially methylated alditol
acetates (PMAAs). Although the proposed protocol was not completely successful, much
has been learned to allow this project to continue with protocol modifications.
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INTRODUCTION
Ethnobotany:
Throughout history, many plants and herbs have been used for their medicinal
properties. Many drugs originated out of the simple plant form, and are now derived and
altered into a pill or capsule for use by the pharmaceutical world. One of the most
common herbal supplements throughout the world is Echinacea, the American
coneflower. The name Echinacea comes from the Greek word echinos, meaning sea
urchin, due to the prickly seed head of this flower. There are nine known species of
Echinacea, but only three of these are used as medicinal herbal supplements (E.
purpurea, E. angustifolia, and E. pallida).1 Most of the supplements are derived from the
aerial or underground parts of E. purpurea, and from the roots of E. angustifolia or E.
pallida. The roots have high concentrations of volatile oils while the above-ground parts
of the plant tend to contain more polysaccharides.10 The various parts of the plants are
approved for different treatments. In Europe the German Commission E. regulates
approved uses based upon primary literature. They medicate or determine minimum
standards of product. Germans have approved the above ground parts of E. purpurea to
treat colds, upper respiratory tract infections, urinary tract infections, and slow healing
wounds, while the root of E. pallida is also approved for flu-like infections.10
Echinacea has not always been a popular supplement. Natural herbal
supplements, including commercially obtained Echinacea (usually one or more of the
following E. purpurea, E. angustifolia, or E. pallida) declined in popularity in the United
State with the advances of antibiotics. However, Echinacea is now one of the most
popular natural supplements in the U.S. and Europe. Native Americans first used
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Echinacea over 400 years ago to treat all infections and wounds.10 Other sources believe
Native Americans used Echinacea to create teas, mouthwashes, and medicinal bandages
for treatments of coughs, dyspepsia, toothaches, stomach cramps, and a variety of other
ailments. It has also been reported that Echinacea can be used to treat snakebites,
headache, and the common cold.1 Echinacea species are endemic to North America and
different species occur in various grassland habitats between the Appalachian and Rocky
Mountains.1
Many herbal supplements use a combination of these two Echinacea species.
There are four main potentially immunologically active components in Echinacea. The
main chemical components within Echinacea are caffeic acid derivatives (cichoric acid,
echinacoside), alkamides, polyacetylenes, and glycoproteins/polysaccharides.1
Echinacea has many chemical components that when combined with one another
produce the medicinal benefits observed originally by Native Americans and that
continue to be observed by many cultures today.
Medicinal/Chemistry:
The mechanism for the immunostimulating effects of Echinacea is not well
understood, and it is still not known which constituents of Echinacea are the bioactive
compounds.18 Some research states that the combination of Echinacea polysaccharides
and the cell matrix surrounding human tissue cells can create a resistance to local
inflammations, which limits bacterial access, increases phagocytosis and other immune
functions to help fight the infection and decrease toxic by-products, which in turn
supports the growth of new tissue.16 There have been many studies attempting to analyze
each of these components to determine their immunological effects. The active
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substances in E. purpurea may enhance the immune system, relieve pain, reduce
inflammation, and have hormonal, antiviral, and antioxidant effects. For this reason
Echinacea can also be used to treat urinary tract infections, yeast infections, ear
infections, athlete’s foot, sinusitis, hay fever and slow-healing wounds.10
Many liquid Echinacea herbal supplements are made using water or alcoholic
extracts. Each of these extracts yields different chemical components within the herbal
plant supplement. The immunostimulatory activity of the alcoholic extracts is largely
due to the lipophilic amides, as well as the polar caffeic acid derivatives, whereas the
water soluble polysaccharides are implicated in the expressed juice or aqueous
preparations.4 Another form of Echinacea herbal supplement is in a capsule form.
However, with most herbal supplements each brand may use multiple species of
Echinacea, various parts of the plant (aerial or root), different growing conditions, and
preparation methods which may affect the amount and or activity of the active
ingredients.
Chemical Analysis:
In this investigation, the polysaccharide chemical composition was determined using
Puritan’s Pride (aerial) herbal supplement and a ChromaDex Botanical Standard (root).
By identifying the polysaccharides present in E. purpurea, each polysaccharide can later
be analyzed for its immunological activity. Polysaccharides are complex carbohydrates.
A single sugar unit is called a monosaccharide, two sugars units linked together is called
a disaccharide, three sugar units linked together is called a trisaccharide, three to 100
sugar units is called an oligosaccharide, and 100+ sugars linked together is called a
polysaccharide (a polymer of monosaccharides).
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Some studies indicate that E. purpurea is rich in polysaccharides and
phytosterols, which causes immune cells to search out bacteria. Previously, scientists
have used nuclear magnetic resonance spectroscopy (NMR), a non-destructive technique
to determine the structure of various organic compounds. However, NMR uses a much
larger sample than Gas Chromatography-Mass Spectroscopy (GC/MS) and is unable to
conclusively identify polysaccharides.
To analyze polysaccharides by GC/MS, they must be chemically converted into
volatiles by a sequential process of methylation, hydrolysis, reduction and acetylation.
This conversion process allows the polysaccharides to be broken down into partially
methylated alditol acetates (PMAAs) which are volatile enough to be analyzed in a
GC/MS. This process also permits the structural elucidation of how the monosaccharides
are linked together to form the original polysaccharide. The general chemical
modification scheme is illustrated below for a simple monosaccharide (glucose- Scheme
1) and a disaccharide (sucrose-Scheme 2):
Scheme 1: Structural procedure for glucose:
1)

Methylation

A DMSO/NaOH slurry is used to deprotonate the OH groups and then CH3I is usedfor
methylation. The red dot represents the anomeric carbon (the alcohol group can occupy
two different orientations- up or down).
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2)

Hydrolysis (only one component since monosaccharide)

Hydrolysis o f the anomeric carbon occurs as a result o f trifluoroacetic acid.
3)

Reduction(necessary to prevent identical, symmetrical derivatives in GC/MS)

Reduction results in opening o f the ring, creation o f an aldehyde, and the conversion o f
the aldehyde to a primary alcohol.
4)

Acetylation

The alcohol groups are acetylated by acetic anhydride and TFA.
Scheme 2: Structural procedure for sucrose:
1)

Methylation
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A DMSO/NaOH slurry is used to deprotonate the OH groups and then CH3I is usedfor
methylation. There are two anomeric carbons associated with a disaccharide.
2) Hydrolysis

The glycosidic bond is broken using TFA and hydrolysis occurs at the anomeric carbons.
3) Reduction

Equilibrium Aldehyde

Equilibrium

Ketone

Reduces to primary alcohol

Reduces to secondary alcohols

The resulting deuteratedproducts can be easily distinguished with GC/MS.
4) Acetylation
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The alcohol groups are acetylated by acetic anhydride and TFA. Each PMAA should be
distinguishable with GC/MS due to the differences in positions o f the anomeric carbons.
GC/MS is an instrument that chemists use to analyze a complex mixture of
volatile compounds. A gas chromatograph first separates the mixture into its individual
components and then a mass spectrometer detector is used to conclusively identify these
components. The combination of these two techniques allows a quantitative and
qualitative analysis of a volatile mixture. In order for a compound to be analyzed by
GC/MS it must be sufficiently volatile since it will be introduced into a gas phase and
thermally stable since the components will need to remain structurally intact prior to
entry into the mass spectrometer.
Gas Chromatography:
The separation of a sample occurs when the sample is injected into the inlet at a
high temperature to ensure volatilization. This is followed by introduction into the
mobile phase (an inert gas, typically helium). The mobile phase then carries the sample
through a capillary column containing a stationary phase to which components are
selectively attracted to varying extents (either polar or non-polar). The column
temperature can also be altered to aid in the separation of the mixture. The compounds
that have lower boiling points will elute or exit the column first while those that have
higher boiling points will elute last. As the compounds elute from the column, they enter
a detector which indicates the presence of a compound: the greater the concentration of
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the compound, the greater the signal. This signal can be measured by determining the
peak area of each elutant’s gas chromatogram. The time interval between the injection
and individual compound detection is called the retention time (tR). Retention time is
useful in determining the identity of a compound; however similar molecular structures
may have similar retention times.
Mass Spectroscopy:
As the individual components elute from the GC column, they enter an ionization
source in a mass spectrometer. Here components are ionized into charged fragments.
The resulting fragments are separated in a mass analyzer and ultimately detected. A total
ion chromatogram (total ion current vs. tR) and a mass spectrum (relative abundance vs.
m/z or mass/charge) are produced.
Guiding Research Questions:
1. In what portion of the plant are polysaccharides most abundant?
2. Can PMAAs be successfully produced from E. purpurea?
3. Can polysaccharides in E. purpurea be identified using GC/MS through linkage
analysis?
EXPERIMENTAL METHODOLOGY
The first procedure, the extraction of polysaccharides from E. purpurea plant
material was adapted from Brovelli (2005).5 This procedure was used to compare the
polysaccharide content in Puritan’s Pride herbal supplement (E. purpurea-aerial) and a
ChromaDex certified botanical standard (E. purpurea -powdered root).
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I. Determination of Crude Polysaccharide Content in E. Purpurea
A crude extract was prepared by adding 35mL of deionized water to 5g of plant
material (Puritan’s Pride E. purpurea (aerial) “non-irradiated” herbal supplement) then
this suspension was incubated in a 90°C water bath for 1 hour. Two samples were run to
ascertain reproducibility. Each sample was cooled to room temperature and then
centrifuged at 4000rpm for 15 min. The supernatant was filtered using Whitman #1
filter paper and gravity filtration, then the volume was adjusted to 20 mL with deionized
water. Polysaccharide precipitation was induced by the addition of 20mL of 99%
ethanol, the samples were vortexed and then refrigerated for 15 min. The sample was
then centrifuged for 25 min at 4000 rpm, and the supernatant was discarded. The pellet
was resuspended in 8 mL of water. After the addition of 32 mL of 99% ethanol, the
sample was vortexed and refrigerated for 15 min. The sample was then centrifuged for 5
min at 4000rpm. The supernatant was discarded, and the pellet was dried in an oven at
65°C for about 15 hrs. The dry mass was then recorded as the crude polysaccharide
fraction and expressed as a percentage.5
The procedure detailed above was also completed with a ChromaDex certified
botanical standard (.E. purpurea -powdered root). The percent by mass content of
polysaccharides was determined and compared to that of the Puritan Pride E. Purpurea.
A subsequent procedure as outlined below used the extracted Puritan Pride
polysaccharides for conversion into volatile alditol acetates using a combined procedure
adapted from Brovelli (2005)5 and Blakeney (1983)3.
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II. Preparation of Alditol Acetates
A. Conversion of Polysaccharide Pellet into Component Monosaccharides
This step was inadvertently left out of the protocol, but it is necessary to add acid
(e.g., HC1) to cleave the glycosidic bond(s) between monosaccharide units.
B. Reduction
The internal standard, myo-lnositol was added (0.05mL of a 20mg/mL solution)
to the polysaccharide pellet. Next, 2.0g of deuterated sodium borohydride (NaBD4) was
dissolved in 100 mL of anhydrous dimethyl sulphoxide (Me2SO or DMSO) at 100°C.
Monosaccharides were reduced for 90 min in a 40°C water bath by adding 3.0 mL of the
NaBD4 solution to 0.1 mL of the monosaccharide mixture. After reduction, the excess
NaBD4 was decomposed by the addition of 0.1 mL of 18M glacial acetic acid (C2H4O2).3
C. Conversion of Monosaccharides into Alditol Acetates
0.2 mL of 1-methylimidazole followed by 2.0 mL of acetic anhydride was added
to the reduced monosaccharides and mixed. After 10 min at room temperature (~21°C),
5.0 mL of deionized water was added to decompose the excess acetic anhydride. When
cool, 1.0 mL of dichloromethane was added and the mixture was vortexed. After the
phases had separated, the lower, organic phase was removed with a Pasteur pipette and
stored in a l.0mL septum-cap vial at -20°C.
D. Analysis of Alditol Acetates using GC/MS
The gas flow rate of high purity helium (carrier gas) was set at lmL/min. The
oven temperature was kept for at 190°C for 4 min following injection and then raised at
4°C/min to 230°C, where it was held for 8 min. The injection port and detector were
heated to 250°C and 300°C respectively. A 1.0 pL sample was injected for analysis.
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III. Preparation of Partially Methylated Alditol Acetates
Further examination of the literature revealed that a useful way to elucidate
carbohydrate structure is linkage analysis, accomplished by the production of
permethylated and peracetylated derivatives prior to GC/MS. A third protocol was
attempted since it provides more information about the structure of the original
polysaccharides, which was not available with the previous protocol. This procedure was
adapted from Kim et. al (2006).15 Prior to working with E. purpurea, it was decided that
establishing the experimental protocol with a less complex carbohydrate was prudent. A
monosaccharide (glucose), a disaccharide (sucrose), and an internal standard (myo
inositol) were all subjected to the experimental protocol below to ensure that PMAAs
could be produced successfully. Once this protocol worked, the procedure would
presumably be useful for E. purpurea. The internal standard, myo-inositol, was used as a
check to insure that the methylation process worked since once it is methylated, it will
not be affected by any other steps during the production of PMAAs. Its presence should
be easily revealed in the mass spectrum ultimately obtained.
A. Polysaccharide Sample Preparation
300pL of l.Omg/mL (lOOOppm) aqueous polysaccharide solutions (sucrose and
glucose) and an internal standard myo-inositol were oven-dried at 100°C until a crystal or
powder was formed.
B. Preparation of PMAAs
1.3.1 Preparation o f NaOH-Me2SO slurry
400pL methanol and 150pL of 50% NaOH (w/v) were added to a Teflon screwcap test tube and vortexed until a clear mixture was obtained. 2.0 mL of DMSO was
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added, followed by vortexing and centrifugation at 6000rpm for 10 min to pellet the
NaOH (an opaque white pellet was formed). The supernant was decanted and the pellet
was washed two times with 2.0 mL of DMSO. The pellet was then resuspended in 2mL
DMSO.
1.3.2 Methylation
The next steps were conducted quickly in a fume hood to minimize the
introduction of moisture into the samples. l 00μL of DMSO was added to each of the
samples. The samples were then vortexed until a clear mixture was obtained. 500μL of
the NaOH slurry was added, then vortexed until clear. l 00μL of CH3I was added and the
samples were vortexed intermittently for 10 minutes until a clear solution remained.
Samples were then dried using nitrogen gas to remove excess CH3I.
1.3.3 Sample clean-up
The samples were partitioned with 2.0mL deionized H2O and 2.0 mL CH2CI2
using a separatory funnel to collect the bottom organic layer. The samples were then
washed 3 times with deionized water, and the final organic phase was dried with nitrogen
gas.
1.3.4 Hydrolysis
250 μL of 2M (mol/L) CF3CO2H (TFA) was added followed by incubation in a
121°C oven for 2 hrs. The samples were brown in color after the 2 hour incubation at
121°C. The samples were dried, followed by two additional dryings with a few drops of
methanol.
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1.3.5 Reduction
Samples were reduced with 0.lmL of l 0mg/mL NaBD4 for 1 hr. at room
temperature. The reduction was quenched with one drop of glacial acetic acid and then
dried. Since glacial acetic acid is not very volatile, it took about 4 hrs. to dry each
sample. The samples were dried three more times with the addition of a few drops of
methanol, followed by evaporation under a stream of nitrogen.
1.3.6 Acetylation
l 00μL of acetic anhydride (AC2O) and 80μL of 2M TFA were added to each
sample, followed by a 10-min incubation at 50°C. 0.5 mL of acetone was added, and the
samples were dried. The samples were then dried an additional two times with a few
drops of acetone, followed by evaporation under nitrogen. The samples were then
cleaned up by partition as previously described in section 1.3.3, and the final organic
phase was dried. The final samples were solubilized in 2.0 mL of CH2Cl2 and 1.0 μL of
the sample was injected into the GC-MS.
1.4 Gas chromatography-mass spectrometry (GC-MS) instrumental parameters
A Thermo-Electron capillary GC column (15m x 0.25 id x 0.25pm, 5% diphenyl)
was used in this experiment. Helium was the carrier gas at a constant flow rate of
lmL/min. The oven conditions were an initial temperate of 50°C held for 2 min,
30°C/min to 150°C, 3°C/min to 220°C and finally 30°C/min to 300°C for a 10 min
bakeout. The inlet temperature was kept constant at 250°C, and the MS transfer line was
set at 300°C. MS acquisition parameters were set up to scan from m/z 50-550 in the
electron impact (EI) mode for routine analysis. Peak assignments were made based on
retention times and mass spectra with the aid of a NIST mass spectral library.
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RESULTS AND DISCUSSION
Determination of Crude Polysaccharide Content in E. Purpurea
The aerial material of E. purpurea contains 7.1% polysaccharides, while the root
only contains 0.12%. Since polysaccharides are believed to be immunologically active,
the aerial part of the plant is generally used for herbal supplements, although many herbal
supplements also use a combination of the aerial and root material. These values agree
with literature, stating that polysaccharide content found within the aerial part of the plant
is greater than the roots.10
Analysis of Alditol Acetates using GC/MS
A TIC (total ion chromatogram) and MS (mass spectrum) were obtained from the
analysis of alditol acetates from Puritan’s Pride E. purpurea. It was expected that mass
fragments characteristic of alditol acetates would be seen. A NIST library search that is
part of the XCalibur software package for our Thermo-Electron Trace GC/Focus DSQ
instrument was performed for each peak of interest obtained in the TIC. The solvent
peaks from the procedure II GC/MS spectrum (figure 1) were identified as methylene
chloride (tR = 1.64 min) and DMSO (tR=3.60 min).

Figure 1: Total Ion Chromatogram o f Procedure II (unmethylated)
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The peak with a tR of 19.01 min was identified as myo-inositol hexaacetate, the
internal standard after acetylation, as a result of a NIST library search. This peak
indicates that the acetylation step was somewhat successful, but may not have been
complete after the 10 min incubation period. The structure of myo-inositol hexaacetate is
shown in figure 2.

Figure 2: Acetylated myo-inositol (myo-inositol hexaacetate)
Figure 3 demonstrates the similarities between the MS of the myo-inositol
hexaacetate peak from the procedure II sample and the NIST standard, similarities are
circled in red.

Figure 3: Procedure II (Unmethylated) sample vs. NIST library match MS o f
myo-inositiol hexaacetate

17

None of the expected alditol acetates were produced from Puritan’s Pride E.
Purpurea as evidenced from the total ion chromatogram (Figure 1).
GC/MS Analysis of Partially Methylated Alditol Acetates
Inspection of the TIC and MS of glucose, sucrose, and myo-inositol revealed only
the presence of the solvent peak (CH2Cl2). This clearly indicates that the expected
PMAAs were not produced in any case. It was noticed that during the production of
PMAAs, dark brown products resulted from the hydrolysis step. This is usually
indicative of degradation and loss of the desired product. All steps prior to this one
revealed a clear solution or white crystals. Figure 4 demonstrates the solvent peak for
methylene chloride.

Figure 4: Total Ion Chromatogram and Mass Spectrum: Procedure III (methylated)
The identity of the solvent peak at tR= 1.16 was verified using the NIST library,
with a 92% probability of being methylene chloride. The main fragments for methylene
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chloride should be 46, 48, 49, 51, 84, 86, and 88. The resulting mass spectrum revealed
fragments due to the solvent at 49, 51, 84, 86, and 88.
Future Research:
If more time were allotted for this project, the second procedure could be tried
again, adding in a methylation and hydrolysis step with just sucrose first prior to working
with E. purpurea, to ensure the successful production of PMAAs. The sample size could
also be scaled up to ensure that enough of the intended product from each step is
produced. Once PMAAs are successfully produced, the reaction could be scaled back
down to a smaller sample size as described in the literature and followed in procedure
three to ensure the successful recovery of PMAAs. Once PMAAs are successfully
produced, then the procedure should be attempted again with polysaccharides isolated
from the E. purpurea aerial herbal supplement (Puritan’s Pride). After each step, TLC
(thin-layer chromatography) or NMR (nuclear magnetic resonance spectrometry) could
be used to ensure the completion of each of the desired reactions. The third procedure
could also be attempted again with a decrease in the oven temperature to hopefully
prevent the decomposition (brown coloration) from occurring during the hydrolysis
reaction. Once the PMAAs are successfully produced, GC/MS instrumental conditions
should be optimized for detection of said PMAAs. After successful identification of the
polysaccharides in E. Purpurea, the polysaccharides can be tested individually to
determine their immunological response in cell cultures. If one polysaccharide is, then it
can be isolated and used for possibly treating upper respiratory infections, colds, and the
flu virus.
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